BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 90 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $516,000 | -34.5% | 400,000 | -46.7% | 0.04% | -64.8% |
| Q3 2019 | $788,000 | -73.0% | 750,000 | +200.0% | 0.12% | -75.4% |
| Q2 2017 | $2,920,000 | +18.3% | 250,000 | +25.0% | 0.50% | +2.9% |
| Q1 2017 | $2,468,000 | -47.4% | 200,000 | -13.6% | 0.48% | -29.8% |
| Q4 2015 | $4,693,000 | +39.5% | 231,515 | +0.0% | 0.69% | +60.1% |
| Q3 2015 | $3,364,000 | -31.7% | 231,514 | 0.0% | 0.43% | -11.0% |
| Q2 2015 | $4,924,000 | -13.5% | 231,514 | -7.2% | 0.48% | -18.7% |
| Q1 2015 | $5,693,000 | – | 249,567 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,026,402 | $21,832,000 | 2.20% |
| Avoro Capital Advisors LLC | 262,515 | $5,584,000 | 1.54% |
| Lamond Capital Partners LLC | 68,780 | $1,463,000 | 1.48% |
| Green Owl Capital Management, LLC | 90,000 | $1,914,000 | 1.36% |
| Baker Brothers Advisors | 4,190,594 | $89,134,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,514 | $4,924,000 | 0.48% |
| Redmile Group, LLC | 238,121 | $5,065,000 | 0.42% |
| Highlander Capital Management, LLC | 19,250 | $409,000 | 0.37% |
| Spark Investment Management LLC | 110,500 | $2,350,000 | 0.33% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 145,380 | $3,092,000 | 0.24% |